These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 19901028

  • 1. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death.
    Kobayashi S, Volden P, Timm D, Mao K, Xu X, Liang Q.
    J Biol Chem; 2010 Jan 01; 285(1):793-804. PubMed ID: 19901028
    [Abstract] [Full Text] [Related]

  • 2. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX, Cheng L, Qin HL, Zhang YZ, Wang LY, Zhang YG.
    Cardiovasc Toxicol; 2019 Jun 01; 19(3):264-275. PubMed ID: 30535663
    [Abstract] [Full Text] [Related]

  • 3. Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity.
    Wu YP, Zhang S, Xin YF, Gu LQ, Xu XZ, Zhang CD, You ZQ.
    Phytomedicine; 2021 Jul 15; 88():153597. PubMed ID: 34111614
    [Abstract] [Full Text] [Related]

  • 4. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo.
    Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM, Liang Q.
    FASEB J; 2006 Apr 15; 20(6):800-2. PubMed ID: 16469847
    [Abstract] [Full Text] [Related]

  • 5. Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury.
    Kobayashi S, Xu X, Chen K, Liang Q.
    Autophagy; 2012 Apr 15; 8(4):577-92. PubMed ID: 22498478
    [Abstract] [Full Text] [Related]

  • 6. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy.
    Bartlett JJ, Trivedi PC, Yeung P, Kienesberger PC, Pulinilkunnil T.
    Biochem J; 2016 Nov 01; 473(21):3769-3789. PubMed ID: 27487838
    [Abstract] [Full Text] [Related]

  • 7. Caloric restriction mimetic 2-deoxyglucose antagonizes doxorubicin-induced cardiomyocyte death by multiple mechanisms.
    Chen K, Xu X, Kobayashi S, Timm D, Jepperson T, Liang Q.
    J Biol Chem; 2011 Jun 24; 286(25):21993-2006. PubMed ID: 21521688
    [Abstract] [Full Text] [Related]

  • 8. Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity.
    Pizarro M, Troncoso R, Martínez GJ, Chiong M, Castro PF, Lavandero S.
    Toxicology; 2016 Aug 31; 370():41-48. PubMed ID: 27666003
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy.
    Xu X, Chen K, Kobayashi S, Timm D, Liang Q.
    J Pharmacol Exp Ther; 2012 Apr 31; 341(1):183-95. PubMed ID: 22209892
    [Abstract] [Full Text] [Related]

  • 10. Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy.
    Chen B, Zhong L, Roush SF, Pentassuglia L, Peng X, Samaras S, Davidson JM, Sawyer DB, Lim CC.
    PLoS One; 2012 Apr 31; 7(4):e35743. PubMed ID: 22532871
    [Abstract] [Full Text] [Related]

  • 11. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
    Li S, Wang W, Niu T, Wang H, Li B, Shao L, Lai Y, Li H, Janicki JS, Wang XL, Tang D, Cui T.
    Oxid Med Cell Longev; 2014 Apr 31; 2014():748524. PubMed ID: 24895528
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction.
    Tony H, Yu K, Qiutang Z.
    Oxid Med Cell Longev; 2015 Apr 31; 2015():597032. PubMed ID: 26137188
    [Abstract] [Full Text] [Related]

  • 13. The involvement of autophagic flux in the development and recovery of doxorubicin-induced neurotoxicity.
    Zhou X, Xu P, Dang R, Guo Y, Li G, Qiao Y, Xie R, Liu Y, Jiang P.
    Free Radic Biol Med; 2018 Dec 31; 129():440-445. PubMed ID: 30336249
    [Abstract] [Full Text] [Related]

  • 14. Ambra1 modulates starvation-induced autophagy through AMPK signaling pathway in cardiomyocytes.
    Shi C, Wu J, Fu M, Zhang B, Wang J, Yang X, Chi Y.
    Biochem Biophys Res Commun; 2014 Sep 26; 452(3):308-14. PubMed ID: 25117440
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F, Zhou X, Wang L, Shan L, Li C, Zhou H, Lee SM, Hoi MP.
    Eur J Pharmacol; 2018 Feb 05; 820():86-96. PubMed ID: 29229534
    [Abstract] [Full Text] [Related]

  • 18. Genistein alleviates doxorubicin-induced cardiomyocyte autophagy and apoptosis via ERK/STAT3/c-Myc signaling pathway in rat model.
    Wu J, Feng A, Liu C, Zhou W, Li K, Liu Y, Shi Y, Adu-Amankwaah J, Yu H, Pan X, Sun H.
    Phytother Res; 2024 Aug 05; 38(8):3921-3934. PubMed ID: 38818771
    [Abstract] [Full Text] [Related]

  • 19. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D, Xue C, Li J, Feng K, Zeng P, Chen Y, Duan Y, Zhang S, Li X, Han J, Yang X.
    Biochem Biophys Res Commun; 2020 Dec 10; 533(3):304-312. PubMed ID: 32958254
    [Abstract] [Full Text] [Related]

  • 20. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X, Zhu Y, Deng Y, Zhang S, Zhang Q, Zhao B, Li G.
    Toxicology; 2020 Aug 10; 441():152508. PubMed ID: 32525084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.